| 11332492 |
CD73 inhibitors and therapeutic uses thereof |
Jian Liu, Linghang Zhuang, Suxing Liu, Rumin Zhang, Feng He +1 more |
2022-05-17 |
|
| 11046714 |
2,2-difluorodioxolo A2A receptor antagonists |
Ali Amjad, Gioconda V. Gallo, Timothy J. Henderson, Rongze Kuang, Yeon-Hee Lim +6 more |
2021-06-29 |
$135,073,000 |
| 10822338 |
Substituted aminoquinazoline compounds as A2A antagonist |
Amjad Ali, Xianhai Huang, Yeon-Hee Lim, Rongze Kuang, Rajan Anand +6 more |
2020-11-03 |
$132,407,000 |
| 10472347 |
Aminopyrazine compounds with A2A antagonist properties |
Rongze Kuang, Pauline C. Ting, Amjad Ali, Michael Y. Berlin, Andrew Stamford +6 more |
2019-11-12 |
$187,990,000 |
| 10138212 |
Aminoquinazoline compounds as A2A antagonist |
Amjad Ali, Rongze Kuang, Yeon-Hee Lim, Michael Man-Chu Lo, Pauline C. Ting +21 more |
2018-11-27 |
$94,550,000 |
| 10093683 |
Factor XIa inhibitors |
Yeon-Hee Lim, Zhuyan Guo, Amjad Ali, Scott D. Edmondson, Weiguo Liu +16 more |
2018-10-09 |
$288,663,000 |
| 10081617 |
Factor XIa inhibitors |
Eric Mertz, Scott D. Edmondson, Sung-Sau So, Wanying Sun, Weiguo Liu +10 more |
2018-09-25 |
$93,342,000 |
| 10011615 |
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties |
Amjad Ali, Michael Man-Chu Lo, Yeon-Hee Lim, Andrew Stamford, Rongze Kuang +14 more |
2018-07-03 |
$73,356,000 |
| 9868727 |
Factor XIa inhibitors |
Weiguo Liu, Scott D. Edmondson, Zhuyan Guo, Sung-Sau So, Anthony Ogawa +6 more |
2018-01-16 |
$61,578,000 |
| 9783530 |
Factor Xla inhibitors |
Weiguo Liu, Scott D. Edmondson, Zhuyan Guo, Eric Mertz, Anthony Ogawa +5 more |
2017-10-10 |
$124,275,000 |
| 9676780 |
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A2A antagonist properties |
Amjad Ali, Michael Man-Chu Lo, Yeon-Hee Lim, Andrew Stamford, Rongze Kuang +19 more |
2017-06-13 |
$92,938,000 |
| 8716312 |
Inhibitors of diacylglycerol acyltransferase |
Pauline C. Ting, Robert G. Aslanian, Mary Ann Caplen, Jianhua Cao, Tin-Yau Chan +7 more |
2014-05-06 |
$63,658,000 |
| 8232274 |
Pyridazinone derivatives useful as glucan synthase inhibitors |
Pauline C. Ting, Robert G. Aslanian, Jianhua Cao, David Kim, Rongze Kuang +5 more |
2012-07-31 |
|
